Lgc
LGC, officially known as LGC Group, is a leading global player in the life sciences and analytical services industry, headquartered in Great Britain. Founded in 1842, LGC has established itself as a trusted partner in various sectors, including pharmaceuticals, food safety, and environmental testing. The company operates extensively across Europe, North America, and Asia, providing a diverse range of services that include laboratory testing, reference materials, and proficiency testing. LGC's core offerings are distinguished by their commitment to quality and innovation, ensuring compliance with stringent regulatory standards. With a strong market position, LGC has achieved notable milestones, such as expanding its capabilities through strategic acquisitions and partnerships. This dedication to excellence has solidified LGC's reputation as a leader in the analytical services landscape, making it an invaluable resource for clients seeking reliable and accurate solutions.
DitchCarbon Score
How does Lgc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lgc's score of 27 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lgc's reported carbon emissions
In 2024, LGC reported total carbon emissions of approximately 28,000,000 kg CO2e, comprising 6,413,000 kg CO2e from Scope 1, 3,888,000 kg CO2e from Scope 2, and 17,500,000 kg CO2e from Scope 3 emissions. This marks a slight decrease from 2023, where total emissions were about 28,000,000 kg CO2e, with Scope 1 emissions at 5,834,000 kg CO2e and Scope 2 emissions at 6,550,000 kg CO2e. LGC has committed to achieving net-zero emissions by 2050, with targets set across all scopes of emissions. The company is actively working towards these long-term goals, having initiated its commitment in 2023. The reduction initiatives are aligned with the Science Based Targets initiative (SBTi), which underscores LGC's dedication to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. Overall, LGC's emissions data reflects a significant focus on reducing its carbon footprint while adhering to industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 12,407,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,122,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,862,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lgc is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
